• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
78,285.07 521.16
( 0.67%)
Global Indices
Nasdaq
53,071.47 150.40
(0.28%)
Dow Jones
7,557.54 53.30
(0.71%)
Hang Seng
69,576.15 -167.92
(-0.24%)
Nikkei 225
10,649.07 -29.96
(-0.28%)
Forex
USD-INR
95.28 0.28
(0.30%)
EUR-INR
108.75 0.54
(0.50%)
GBP-INR
126.99 1.06
(0.84%)
JPY-INR
0.59 0.01
(0.97%)

EQUITY - MARKET SCREENER

Kimia Biosciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
530313
INE285U01025
3.7455607
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
20.1
149.32
EPS(TTM)
Face Value()
Div & Yield %
1.57
1
0
 

Themis Medicare reports consolidated net profit of Rs 8.89 crore in the March 2026 quarter
May 28,2026
Net profit of Themis Medicare reported to Rs 8.89 crore in the quarter ended March 2026 as against net loss of Rs 9.66 crore during the previous quarter ended March 2025. Sales rose 6.74% to Rs 76.53 crore in the quarter ended March 2026 as against Rs 71.70 crore during the previous quarter ended March 2025.

For the full year,net profit declined 96.18% to Rs 1.14 crore in the year ended March 2026 as against Rs 29.83 crore during the previous year ended March 2025. Sales declined 15.60% to Rs 342.24 crore in the year ended March 2026 as against Rs 405.51 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales76.5371.70 7 342.24405.51 -16
OPM %4.91-10.73 -0.1212.10 -
PBDT11.66-8.60 LP 13.1249.60 -74
PBT9.06-11.13 LP 2.8039.67 -93
NP8.89-9.66 LP 1.1429.83 -96